Matrix Metalloproteinases Increase Due to Hypoperfusion in Obstructive Hypertrophic Cardiomyopathy.
Myocardial fibrosis (MF) is considered a result of microvascular dysfunction in patients with...
Read MoreAug 3, 2020
Myocardial fibrosis (MF) is considered a result of microvascular dysfunction in patients with...
Read MoreMay 5, 2020
Hypertrophic cardiomyopathy (HCM) is a common inherited monogenic disease with a prevalence of...
Read MoreMar 12, 2020
Differences in presentation and natural history of hypertrophic cardiomyopathy (HC) between...
Read MoreMar 4, 2020
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease with a broad...
Read MoreFeb 18, 2020
A greater understanding of the pathogenic mechanisms underpinning hypertrophic cardiomyopathy...
Read MoreFeb 13, 2020
A greater understanding of the pathogenic mechanisms underpinning hypertrophic cardiomyopathy...
Read MoreDec 5, 2019
Outcome differences may be associated with inequities in clinical care, authors suggest
Read MoreOct 25, 2012
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic heart diseases in the United...
Read MoreMar 13, 2023
Epidemiology of wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) remains poorly defined. A...
Read MoreOct 19, 2022
The mitochondrial DNA mutation MT-TL1 m.3243A>G causes maternally inherited mitochondrial...
Read MoreJun 17, 2021
Diabetic cardiomyopathy (DCM), one severe complication in the diabetes, leads to high mortality in the diabetic patients. However, the understanding of molecular mechanisms underlying DCM is far from completion. Herein, we...
Read MoreMar 4, 2021
Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease...
Read MoreSep 21, 2020
Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial...
Read MoreMar 18, 2020
Nitroxyl (HNO), one-electron reduced and protonated sibling of nitric oxide (NO), is a potential...
Read MoreMay 28, 2019
Risk increased even at BMI considered normal; more than eightfold greater risk seen for BMI ≥35 kg/m²
Read MoreOct 26, 2024
The following is a summary of “Impact of Ablation on AF burden and symptoms in HCM,” published in...
Read MoreSep 13, 2024
The following is a summary of “French hypertrophic cardiomyopathy gene register: A systematic...
Read MoreAug 22, 2024
The AHA and ACC 2024 Clinical HCM management guidelines include revised and new recommendations regarding ICD placement, atrial fibrillation, and more.
Read MoreJul 31, 2024
The following is a summary of “Risk profiles for ventricular arrhythmias in hypertrophic...
Read MoreJul 27, 2024
A recent study investigated the relationship between plasma free fatty acids (FFA) and HCM. In a study published online in BMC Cardiovascular Disorders, authors focused on the clinical importance of FFA metabolism in patients...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.